(Q37625921)

English

New oral drugs for multiple sclerosis

scientific article published on October 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

title

New oral drugs for multiple sclerosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21 August 2017

0 references

Claudio Gasperini

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

S Ruggieri

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

publication date

1 October 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

published in

Neurological Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

volume

30 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

page(s)

S179-83

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

exact match

https://scigraph.springernature.com/pub.10.1007/s10072-009-0146-3

0 references

cites work

Whole brain volume changes in patients with progressive MS treated with cladribine.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10072-009-0146-3

retrieved

21 January 2018

Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10072-009-0146-3

retrieved

21 January 2018

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10072-009-0146-3

retrieved

21 January 2018

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10072-009-0146-3

retrieved

21 January 2018

Identifiers

DOI

10.1007/S10072-009-0146-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

PubMed publication ID

19882371

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19882371

retrieved

21 August 2017

(Q37625921)

New oral drugs for multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)